Biosimilars: Designing and Building the Clinical Package
Date: | 10-Mar-15 to 10-Mar-15 |
Location: | Holiday Inn Bloomsbury / London / United Kingdom |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
The patent expiry of a number of biologics that have revolutionised medical practice is imminent. Numerous programs have been initiated to develop corresponding follow-on products. Regulatory agencies have issued guidance on abbreviated clinical requirements for marketing authorisations tailored to such replicates.
This workshop will provide a detailed overview over the thinking behind the abbreviated clinical evidence base, and the purpose the different components serve. The Master-class will speak to aspects such as the “sensitivity” of the selected clinical model, the role of clinical evidence in the “totality of evidence”, as well as operational aspects of the clinical trials. As product safety plays a central role in stakeholder expectations particular attention will be given to means to address this important topic.
Why you should attend:
• Biosimilars has become a very active and exciting arena.
• This masterclass will give you valuable insights into the principles that shape this space, including its challenges and opportunities
• Network with your peers and gain new and valuable insights
Hosted by: Uwe Gudat, Head of Safety Biosimilars, Merck Serono
HOW TO REGISTER
Book before 30th January & save £100
Register online at www.smi-online.co.uk/2015biosimilars-masterclass1.asp
Contact Magdalena Georgieva on +44 (0) 20 7827 6148 or mgeorgieva@smi-online.co.uk
This workshop will provide a detailed overview over the thinking behind the abbreviated clinical evidence base, and the purpose the different components serve. The Master-class will speak to aspects such as the “sensitivity” of the selected clinical model, the role of clinical evidence in the “totality of evidence”, as well as operational aspects of the clinical trials. As product safety plays a central role in stakeholder expectations particular attention will be given to means to address this important topic.
Why you should attend:
• Biosimilars has become a very active and exciting arena.
• This masterclass will give you valuable insights into the principles that shape this space, including its challenges and opportunities
• Network with your peers and gain new and valuable insights
Hosted by: Uwe Gudat, Head of Safety Biosimilars, Merck Serono
HOW TO REGISTER
Book before 30th January & save £100
Register online at www.smi-online.co.uk/2015biosimilars-masterclass1.asp
Contact Magdalena Georgieva on +44 (0) 20 7827 6148 or mgeorgieva@smi-online.co.uk
Exhibitors
Uwe Gudat, Head of Safety Biosimilars, Merck Serono
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today